Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

318
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
318
Tissue Transplantation01:24

Tissue Transplantation

352
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
352
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

HLA matching in contemporary haematopoietic cell transplantation: Recommendations from the EBMT Practice Harmonisation and Guidelines Committee.

Bone marrow transplantation·2026
Same author

Impact of Modern Strategies for Graft-Versus-Host Disease Prophylaxis on Relapse Risk in Matched-Sibling or Unrelated Donor Hematopoietic Cell Transplantation: A Systematic Review and Meta-Analysis of Randomized Trials.

European journal of haematology·2026
Same author

FALSE POSITIVE REACTION AGAINST 73ID EPLET IN SINGLE ANTIGEN BEAD ASSAY.

Human immunology·2026
Same author

Transplantation in Low and Middle-Income Countries: the Mexican Experience.

Transplantation and cellular therapy·2026
Same author

Antithymocyte globulin and posttransplant cyclophosphamide in graft vs. host disease prophylaxis: comparison or combination.

Current opinion in hematology·2025
Same author

Association Between HLA-DRB1 Serotype and HLA-DQB1 Allele Mismatches and Acute Rejection in Kidney Transplantation.

HLA·2025

相关实验视频

Updated: Jun 19, 2025

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

14.6K

在全原干细胞移植中进行捐赠者选择.

Francisco Barriga1, Alberto Cardoso Martins Lima2

  • 1Section of Hematology, Oncology and Stem Cell Transplantation, Pontificia Universidad Católica de Chile, Stem Cell Collection Center, Fundación de Beneficiencia Pública DKMS, Santiago, Chile.

Current opinion in hematology
|July 24, 2024
PubMed
概括

血液造血干细胞移植的捐赠者选择正在随着人类白细胞抗原 (HLA) 类型的进步而发展. 虽然匹配的兄弟姐妹仍然是理想的,但替代捐赠者越来越多的可行选择.

更多相关视频

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.3K
Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
08:53

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Published on: August 31, 2016

15.2K

相关实验视频

Last Updated: Jun 19, 2025

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

14.6K
Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.3K
Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
08:53

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Published on: August 31, 2016

15.2K

科学领域:

  • 血液学 血液学 血液学
  • 免疫遗传学 免疫遗传学
  • 移植科学 移植科学

背景情况:

  • 人类白细胞抗原 (HLA) 鉴定和供体池扩张的进步增加了供体可用性,用于全源造血干细胞移植.
  • 新的哈普罗同一移植平台进一步扩大了供体选择.

研究的目的:

  • 分析捐赠者类型,影响捐赠者选择的HLA和非HLA因素,以及血液恶性瘤的比较结果.
  • 审查当前在全源造血干细胞移植中供体选择的情况.

主要方法:

  • 关于HLA类型,供体选择算法和比较结果研究的最新文献的综述.
  • 对回顾性研究进行分析,比较不同类型的捐赠者及其对移植成功的影响.

主要成果:

  • HLA类型的进步将更多的位点和等位基 (例如,HLA A,B,C,DRB1,DQB1,DPB1) 纳入供体选择中.
  • 一个共识有利于匹配的兄弟捐赠者,其次是匹配的无关捐赠者,替代捐赠者 (haploidentical,不匹配的无关,带血) 获得了吸引力.
  • 捐赠者的年龄,患者的病情,移植的紧迫性和成本等因素正在挑战传统的捐赠者选择等级.

结论:

  • 在造血干细胞移植中选择供体是复杂的,平衡HLA匹配与临床和后勤因素.
  • 了解与每个捐赠者类型相关的独特特征和结果对于优化患者治疗至关重要.
  • 持续的研究和比较研究对于完善血液恶性瘤的供体选择策略至关重要.